A streptozotocin-induced diabetic model, similar to that of T1DM, was used because we wanted to examine how adropin would affect the plasma levels of insulin and glucagon, the major hormones that are altered after the onset of DM. The gene discussed is INS; the disease is diabetes mellitus.